INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Dec 13, 2019 |
SVP Commercial
Trans History: 141
|
SVP Commercial | Form 4 | Other acquisition or disposition | -- | -- | 50 |
May 06, 2013 |
Director
Trans History: 312
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 50 | $23.84 | 50 |
May 06, 2013 |
Director
Trans History: 312
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 50 | $19.69 | 50 |
Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 660
|
SVP, Therap & Clin Prog Dev | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 400 | -- | 48 |
Oct 01, 2008 |
VP, Controller and Asst. Treas
Trans History: 372
|
VP, Controller and Asst. Treas | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 37 | $9.49 | 37 |
Aug 06, 2015 |
SVP Finance & CFO
Trans History: 465
|
SVP Finance & CFO | Form 4 | Other acquisition or disposition | -- | -- | 35 |
Apr 09, 2015 |
SVP Finance & CFO
Trans History: 465
|
SVP Finance & CFO | Form 4 | Other acquisition or disposition | -- | -- | 35 |
Oct 07, 2022 |
SVP Controller
Trans History: 306
|
SVP Controller | Form 4 | Other acquisition or disposition | -- | -- | 25 |
Oct 07, 2022 |
SVP Controller
Trans History: 306
|
SVP Controller | Form 4 | Other acquisition or disposition | -- | -- | 25 |
Oct 05, 2022 |
SVP Controller
Trans History: 306
|
SVP Controller | Form 4 | Other acquisition or disposition | -- | -- | 25 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.